| ||
| TradersHuddle.com - Synta Announces Phase 2b/3 Trial for ... Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to ... cdn.tradershuddle.com/.../3-Trial-for-Ganetespib-STA-9090-i... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment